Pulseless ventricular tachycardia interventions: Difference between revisions
Homa Najafi (talk | contribs) |
Homa Najafi (talk | contribs) |
||
| Line 32: | Line 32: | ||
| colspan="1" style="text-align:center; background:LemonChiffon"|[[ESC guidelines classification scheme#Classification of Recommendations|Class IIa]] | | colspan="1" style="text-align:center; background:LemonChiffon"|[[ESC guidelines classification scheme#Classification of Recommendations|Class IIa]] | ||
|- | |- | ||
|bgcolor="LemonChiffon" |<nowiki></nowiki>'''1.''' CPR should be performed in patients in cardiac arrest according to published basic and advanced cardiovascular life support algorithms''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: A]]).''.<nowiki/> | |bgcolor="LemonChiffon" |<nowiki></nowiki>'''1.''' [[Cardiopulmonary resuscitation|CPR]] should be performed in patients in [[cardiac arrest]] according to published basic and advanced cardiovascular life support algorithms''([[ACC AHA Guidelines Classification Scheme#Level of Evidence|Level of Evidence: A]]).''.<nowiki/> | ||
|- | |- | ||
|} | |} | ||
Revision as of 17:26, 20 May 2020
|
Pulseless ventricular tachycardia Microchapters |
|
Differentiating Pulseless ventricular tachycardia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Pulseless ventricular tachycardia interventions On the Web |
|
American Roentgen Ray Society Images of Pulseless ventricular tachycardia interventions |
|
Risk calculators and risk factors for Pulseless ventricular tachycardia interventions |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aisha Adigun, B.Sc., M.D.[2]
Overview
There are no recommended therapeutic interventions for the management of [disease name].
OR
[name of intervention] is not the first-line treatment option for patients with [disease name]. [name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The mainstay of treatment for [disease name] is medical therapy/surgery. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of [name of intervention] depends on the stage of [disease or malignancy] at the time of diagnosis.
OR
[Name of intervention] is the mainstay of treatment for [disease or malignancy].
Indications
The mainstay of treatment for TT is medical therapy.
Recommendations for Autonomic Modulation
| Class IIa |
| 1. CPR should be performed in patients in cardiac arrest according to published basic and advanced cardiovascular life support algorithms(Level of Evidence: A).. |